Oramed grants CFO Gabay 357,000-share conditional award
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ORAMED PHARMACEUTICALS INC. granted Chief Financial Officer Avraham Gabay two restricted stock awards on November 12, 2026: 357,000 shares and 242,000 shares, under its Amended and Restated 2019 Stock Incentive Plan. The 357,000-share award vests only if fiscal 2026 return on equity exceeds 18% and is subject to continued service. The 242,000-share award represents annual awards for fiscal years 2027 and 2028 and vests in quarterly installments, subject to continued service. The company stated that no annual award will be granted for fiscal 2028.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 357,000 | -- | -- |
| Grant/Award | Common Stock F2 | 242,000 | -- | -- |
Footnotes (2)
- F1. On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 357,000 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan. The shares vest only if the issuer's return on equity for fiscal year 2026 exceeds 18%, in which case 50% vest on the date the issuer's audited fiscal year 2026 financial statements are published and 50% vest six months thereafter, subject to the reporting person's continued service. If the condition is not met, all of the shares will be forfeited.
- F2. On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 242,000 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's annual awards for fiscal years 2027 and 2028. Of these shares, 121,000 vest in twelve substantially equal quarterly installments beginning January 1, 2027, and 121,000 vest in twelve substantially equal quarterly installments beginning January 1, 2028, in each case subject to the reporting person's continued service. No annual award will be granted to the reporting person for fiscal year 2028.
Key Figures
Key Terms
restricted stock award financial
return on equity financial
vest financial
substantially equal quarterly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.